January 31st 2023
In light of novel targeted agents made available to patients with AML, panelists consider the value of timely molecular testing in this setting.
January 24th 2023
Expert perspectives on current classification strategies in acute myeloid leukemia and how these guidelines make use of molecular markers.
Opening their discussion on the management of acute myeloid leukemia (AML), expert oncologists provide an overview on the incidence, diagnosis, and stratification of patients.